Glen Eagle Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $65.8K | Sell |
|
|||||
|
2025
Q2 | $66.2K | Sell |
|
|||||
|
2025
Q1 | $86.3K | Hold |
|
|||||
|
2024
Q4 | $96.9K | Hold |
|
|||||
|
2024
Q3 | $143K | Hold |
|
|||||
|
2024
Q2 | $143K | Buy |
|
|||||
|
2024
Q1 | $121K | Sell |
|
|||||
|
2023
Q4 | $112K | Hold |
|
|||||
|
2023
Q3 | $105K | Hold |
|
|||||
|
2023
Q2 | $92K | Hold |
|
|||||
|
2023
Q1 | $105K | Sell |
|
|||||
|
2022
Q4 | $93.1K | Buy |
|
|||||
|
2022
Q3 | $88.2K | Sell |
|
|||||
|
2022
Q2 | $80.4K | Hold |
|
|||||
|
2022
Q1 | $95K | Hold |
|
|||||
|
2021
Q4 | $85.9K | Hold |
|
|||||
|
2021
Q3 | $82.3K | Sell |
|
|||||
|
2021
Q2 | $78.8K | Sell |
|
|||||
|
2021
Q1 | $95.1K | Sell |
|
|||||
|
2020
Q4 | $121K | Sell |
|
|||||
|
2020
Q3 | $146K | Hold |
|
|||||
|
2020
Q2 | $162K | Buy |
|
|||||
|
2020
Q1 | $74.2K | Buy |
|
|||||
|
2019
Q4 | $16.9K | Hold |
|
|||||
|
2019
Q3 | $12.5K | Hold |
|
|||||
|
2019
Q2 | $14.1K | Hold |
|
|||||
|
2019
Q1 | $18.5K | Hold |
|
|||||
|
2018
Q4 | $16.8K | Hold |
|
|||||
|
2018
Q3 | $18.2K | Hold |
|
|||||
|
2018
Q2 | $15.5K | Hold |
|
|||||
|
2018
Q1 | $15.5K | Hold |
|
|||||
|
2017
Q4 | $16.9K | Hold |
|
|||||
|
2017
Q3 | $20.1K | Hold |
|
|||||
|
2017
Q2 | $22.1K | Hold |
|
|||||
|
2017
Q1 | $17.4K | Hold |
|
|||||
|
2016
Q4 | $16.5K | Buy |
|